Phase IV study to evaluate the safety and efficacy of clevudine compared with clevudine and vaccine in patients chronically infected with HBV, HBeAg(+)
Phase of Trial: Phase IV
Latest Information Update: 21 Dec 2010
At a glance
- Drugs Clevudine; Hepatitis B vaccine
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Bukwang Pharmaceutical
- 21 Dec 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Dec 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
- 13 Aug 2007 New trial record.